SCHEMBL12820143

SCHEMBL12820143

CC1(C)CC(=O)n2c(c(-c3cc(F)c(C(N)=O)c(N[C@H]4CC[C@H](O)CC4)c3)c3ccc(F)cc32)C1

nearest known ligand 0.47

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 19/20 0.47
HSP90AB1 P08238 18/20 0.47
HSP90B1 P14625 6/20 0.43
TRAP1 Q12931 5/20 0.43
CSNK1E P49674 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12850347 0.93 HSP90AA1 (0.43) HSP90AA1HSP90AB1HSP90B1TRAP1CSNK1E
SCHEMBL12819516 0.92 HSP90AA1 (0.47) HSP90AA1HSP90AB1HSP90B1TRAP1CSNK1E
SCHEMBL12820158 0.92 HSP90AA1 (0.51) HSP90AA1HSP90AB1HSP90B1TRAP1CSNK1E
SCHEMBL12820015 0.92 HSP90AA1 (0.42) HSP90AA1HSP90AB1HSP90B1TRAP1
SCHEMBL12819315 0.91 HSP90AA1 (0.44) HSP90AA1HSP90AB1HSP90B1TRAP1CSNK1E
SCHEMBL12819931 0.90 HSP90AA1 (0.40) HSP90AA1HSP90AB1HSP90B1TRAP1CSNK1E
SCHEMBL12820155 0.89 HSP90AA1 (0.45) HSP90AA1HSP90AB1HSP90B1TRAP1
SCHEMBL12820374 0.89 HSP90AA1 (0.57) HSP90AA1HSP90AB1HSP90B1TRAP1CSNK1E
SCHEMBL12820164 0.88 HSP90AA1 (0.57) HSP90AA1HSP90AB1HSP90B1TRAP1
SCHEMBL12819521 0.88 HSP90AA1 (0.44) HSP90AA1HSP90AB1HSP90B1TRAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012126084-A1 HSP-90 BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND THEIR USE IΝ THE TREATMENT AND PREVENTION OF FUNGAL INFECTIONS PHARMASCIENCE INC. (CA) 2012-09-27 WO disclosed
WO-2011035417-A1 HSP-90 BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND THEIR USE FN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES AEGERA THERAPEUTICS INC. (CA) 2011-03-31 WO disclosed